Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
for
Chagas Disease
Location: Sylmar CA, Houston TX, Gainesville FL, Boston MA
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 60
Code: NCT06632600
Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Duarte CA, Orange CA, Irvine CA, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase 1, Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for
Gout
Location: Tujunga CA, Covina CA, Northridge CA, Norco CA,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089875
Phase 3, Recruiting
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
for
Metastatic Malignant Solid Neoplasm,
Location: Duarte CA, Orange CA, Irvine CA, Sacramento CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05372614
Phase 1, Recruiting
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
for
Gastrointestinal Neoplasms
Location: Los Angeles CA, Whittier CA, Santa Monica CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06885034
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
for
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Location: Duarte CA, Tigard OR, Waukesha WI, Morgantown WV,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07564141
Phase 3, Recruiting
Assessing Improvements in Mood and Sleep Trial
for
Depression, Suicidality, Sleep
Location: Los Angeles CA, Augusta GA, Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 55+
Code: NCT06639477
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
for
Venous Thromboembolism (VTE)
Location: Riverside CA, St. George UT, Englewood CO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07015905
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
for
Heart Failure
Location: Beverly Hills CA, Lake Forest CA, Santa Maria CA,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06991257
Phase 2, Recruiting
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
for
Cushing Disease
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT05971758
Phase 2, Recruiting
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Duarte CA, St Louis MO, Nashville TN, Atlanta GA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07544654
Phase 3, Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Duarte CA, Goodyear AZ, Houston TX, St Louis MO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase 1, Phase 2, Recruiting
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
for
Carcinoma, Non-Small-Cell Lung
Location: Duarte CA, Irvine CA, Portland OR, Toronto
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07586202
Phase 2, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Los Angeles CA, Oregon City OR, Newberg OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
OM336 in Autoimmune Cytopenias
for
AIHA - Warm Autoimmune Hemolytic Anemia,
Location: Duarte CA, Seattle WA, Ann Arbor MI, Washington D.C. DC
Sponsor: Lakefront Biotherapeutics West LLC
Sex: All
Age: 18 - 70+
Code: NCT07083960
Phase 1, Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Santa Ana CA, Henderson NV, El Paso TX, Austin TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 65
Code: NCT07096674
Phase 2, Recruiting
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
for
CTCL
Location: Duarte CA, Rochester NY, Richmond VA, New Haven CT,
Sponsor: Prescient Therapeutics, Ltd.
Sex: All
Age: 18+
Code: NCT06854653
Phase 2, Recruiting
Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease
for
Steroid Refractory GVHD
Location: Duarte CA, Los Angeles CA, St Louis MO, Cincinnati OH,